Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial of SGN-30 (brentuximab vedotin) in combination with chemotherapy for relapsed or refractory Hodgkin lymphoma reported results.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Pilot Study of Unrelated Cord Blood Transplantation [Phase 2]
Phase 2 pilot trial of unrelated cord blood transplantation sponsored by King's College Hospital NHS Trust has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 study of Galiximab for relapsed or refractory Hodgkin lymphoma has completed; results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-02-04Clinical Trial Update: Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes [NA]
This clinical trial update describes evaluating interim PET scans to guide therapy modification in advanced Hodgkin lymphoma in an effort to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Breast-Sparing Proton Therapy for Hodgkin's Disease [EARLY_Phase 1]
An early-phase trial of breast-sparing proton therapy for Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]
This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease [Phase 2]
Phase 2 trial evaluating TG-0054 alone or with G-CSF in multiple myeloma and lymphomas; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) [Phase 1]
Phase 1 pharmacology study update of Brentuximab vedotin (SGN-35) has completed, according to clinical trials data. The study involves patie…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies [Phase 1]
Phase I open-label dose-finding study of SGN-35 (brentuximab vedotin) for CD30-positive hematologic malignancies, including non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma [Phase 1]
This update reports the completion of a Phase 1 study evaluating brentuximab vedotin in combination with multi-agent chemotherapy for Hodgki…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies [Phase 1]
An early-phase Phase I dose-escalation study of Brentuximab vedotin (SGN-35) alone and in combination with gemcitabine for CD30-positive mal…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Cardiac Safety Study of Brentuximab Vedotin (SGN-35) [Phase 1]
Phase 1 cardiac safety study of brentuximab vedotin (SGN-35) has completed, providing early safety data in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma [Phase 2]
This update reports on a Phase 2 trial evaluating combination chemotherapy in younger patients with Hodgkin lymphoma. The study status is co…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives [Phase 2]
Phase 2 clinical trial investigating a two-step bone marrow transplant using cells from two partially matched relatives was terminated; resu…
-
FDA approval · 2014-11-05FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for doxorubicin hydrochloride (Fresenius Kabi USA, LLC) under anANDA to support its generic product.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia [Phase 1]
Phase 1 study of RO4929097, a gamma-secretase inhibitor, in pediatric patients with relapsed or refractory solid tumors, CNS tumors, lymphom…
-
CLINICAL_TRIALS research · 2014-10-27Clinical Trial Update: Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Brentuximab Vedotin followed by ABVD in patients with previously untreated Hodgkin lymphoma.
-
FDA approval · 2014-10-25FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. to market a generic cyclophosphamide product.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps [Phase 1, Phase 2]
This Phase 1/2 study evaluated a two-step reduced-intensity conditioning regimen for bone marrow transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Investigation of the Cylex® ImmuKnow® Assay
A completed clinical trial investigating the Cylex ImmuKnow immune function assay across several hematologic diseases.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE [NA]
A clinical trial evaluating REGKINE for T-regulatory cell kinetics in stem cell transplantation was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: T-Reg Cell Kinetics, Stem Cell Transplant, REGALE [NA]
A terminated clinical trial (NCT00578539) from Baylor College of Medicine studied regulatory T cell kinetics in stem cell transplantation, w…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease [Phase 2]
Phase 2 trial evaluating combination chemotherapy with or without radiation for high-risk Hodgkin lymphoma. The study was terminated.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating Oncaspar (pegaspargase), Doxil (liposomal doxorubicin), and Decadron (dexamethasone) in refractory lymphoid maligna…